HIGH THROUGHPUT GENOMICS, INC.

Basic Information

3430 E. Global Loop
TUCSON, AZ, 85706-

Company Profile

n/a

Additional Details

Field Value
DUNS: 020238841
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Nuclease Probe Mediated Sequencing

    Amount: $1,599,493.00

    This Phase II proposal will complete the development of an innovative sequencing platform (NPSeq) based on feasibility demonstrated in Phase I. This platform uses a nuclease protection assay combined ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. qBead Assessment of miRNA in Alzheimer's Disease

    Amount: $309,019.00

    DESCRIPTION (provided by applicant): miRNA biomarkers related to Alzheimer's disease (AD) that may be useful as a diagnostic tool or in elucidating the mechanisms of disease and discovery of nove ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. Nuclease Probe Mediated Sequencing

    Amount: $599,268.00

    DESCRIPTION (provided by applicant): Sequencing is very powerful for identifying differences in genomic DNA that may regulate cell function and diseases, pre-dispose persons to certain diseases, or wa ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. Not Available

    Amount: $149,371.00

    This Phase I proposal will develop and validate assays to measure the metabolism of compounds  and their affect on liver cells using a multiplexed gene expression assay platform, the quantitative ...

    SBIR Phase I 2010 Department of Health and Human Services
  5. Not Available

    Amount: $149,967.00

    A molecular test using FFPE tissue from patients to distinguish basal-like breast cancer from other subtypes will be developed and confirmed. The test will be based on a commercial platform, the lysis ...

    SBIR Phase I 2010 Department of Health and Human Services
  6. Screening Test for HPV+ Head and Neck Cancer

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): There is currently no good way to screen for early stages of head and neck cancers caused by high risk types of human papillomavirus. The objective of this proposa ...

    SBIR Phase I 2010 Department of Health and Human Services
  7. In Vitro Gene Expression Model Predicting Drug Induced Liver Disease

    Amount: $451,831.00

    DESCRIPTION (provided by applicant): Phospholipidosis (PLDosis) or lipid metabolism disorders are a factor in many drug induced liver diseases. Drug induced, dose-dependent, alterations in the express ...

    SBIR Phase I 2009 Department of Health and Human Services
  8. miRNA HD Array Platform

    Amount: $775,229.00

    DESCRIPTION (provided by applicant): This application is a first resubmission of a Phase I application. An area of special interest to NIAID for SBIR/STTR applications is Biomarkers of Host Immune De ...

    SBIR Phase I 2009 Department of Health and Human Services
  9. Microfluidic Multiplexed mRNA Biomarker Platform

    Amount: $299,436.00

    DESCRIPTION (provided by applicant): The objective of this Phase I 2nd resubmitted proposal is to demonstrate the feasibility of establishing a screening assay and platform (SP-qNPA Microfluidic Scree ...

    SBIR Phase I 2008 Department of Health and Human Services
  10. Whole Genome qNPA Gene Expression Platform

    Amount: $274,583.00

    DESCRIPTION (provided by applicant): The identification of gene targets for drug discovery, including AIDS research and mental health, relies heavily on the use of high density array whole genome pl ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government